Hematology - Jan 31, 2024 - Study predicts snoring could increase the risk of stroke

Can't see this email? View it online

	Hematology
	The latest hematology news from News Medical

	Study predicts snoring could increase the risk of stroke In a recent study published in The Lancet Regional Health, researchers conducted a Mendelian randomization (MR) analysis to understand the causal effect of snoring on total stroke, hemorrhagic stroke (HS), and ischemic stroke (IS) among Chinese adults using data from the China Kadoorie Biobank (CKB).

	Antiviral hope emerges as viruses linked to multiple myeloma A few years ago, a patient was cured of multiple myeloma after being treated for hepatitis C, astounding researchers from the group led by Joaquín Martínez, from the H12O-CNIO Haematological Tumours Clinical Research Unit, a collaboration between the Hospital 12 de Octubre (H12O) and the National Cancer Research Centre (CNIO).

			Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024 NewsMedical speaks with Chao Ma, Ph.D. a Research Assistant Professor at New York University Tandon School of Engineering, ahead of his presentation at SLAS 2024.

			Exploring pharmacological, non-pharmacological, and stem cell therapies for treatment of autism spectrum disorders A research study, led by Maurizio Battino and Francesca Giampieri, with a group of researchers from the Universidad Europea del Atlántico (European University of the Atlantic, UNEATLANTICO), published in the journal "Pharmacological Research", studies various pharmacological, non-pharmacological, and stem cell therapies for the treatment of autism spectrum disorders.

			COST Action bridges the gap in cancer immunotherapy research Cancer is still a leading cause of death worldwide. Globally, there were an estimated 20 million new cases of cancer and 10 million deaths.

	Penn analysis shows low risk of secondary cancers following CAR T cell therapy The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, researchers from the Perelman School of Medicine at the University of Pennsylvania reported today in Nature Medicine.

	AI-driven algorithm accurately predicts death, complications after percutaneous coronary intervention When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI.

	Gene activity plays key role in immune cell production, study shows As people age or become ill, their immune systems can become exhausted and less capable of fighting off viruses such as the flu or COVID-19.

	Persistent presence of SARS-CoV-2 RNA found in long COVID patients Researchers conduct blood digital transcriptomics to determine the persistence of SARS-CoV-2 RNA in patients with long COVID-19.

	New device rapidly provides white blood cell count with a single drop of blood A Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person's white blood cells with a single drop of blood, similar to the way glucometers rapidly scan for blood sugar levels.

	How does a plant-based diet affect pregnancy outcomes? A study in Acta Obstetricia et Gynecologica Scandinavica examines the impact of plant-based diets during pregnancy, revealing that vegan diets are linked to lower birth weights and higher pre-eclampsia risks compared to omnivorous or vegetarian diets.

	Study finds patients with long COVID exhibit complement dysregulation with signs of thromboinflammation Researchers explore inflammatory signatures restricted to patients with active post-acute COVID-19 sequelae.

	AI scores breakthrough in anemia treatment with novel PHD inhibitor Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal focusing on critical studies about molecular structure and biological activity, has published the company's discovery of a novel PHD inhibitor for the treatment of anemia.

	Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.

	Low-dose radiation shows promise as treatment for brain injury and stroke Traumatic brain injury (TBI) and ischemic stroke are major public health concerns and leading causes of death and disability worldwide.

	Early warning sign for myeloma found in bone marrow fat cells A new research perspective was published in Oncotarget's Volume 15 on January 16, 2024, entitled, "Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma."

	Researchers uncover the role of inherited genetic variants in rare type of blood cancer Large-scale genetic analysis has helped researchers uncover the interplay between cancer-driving genetic mutations and inherited genetic variants in a rare type of blood cancer.

	Review of traditional treatments and novel nutritional interventions for sickle cell disease Nutrition-related studies involving sickle cell disease (SCD) patients, particularly those in Africa.

	Study addresses knowledge gap of clinical features and outcomes of Black patients with melanoma Researchers identified patient- and tumor-level melanoma features in black individuals.